Stratec Se Stock

Stratec Se Current Liabilities

The Current Liabilities of Stratec Se (SBS.DE) as of Aug 15, 2026 is 49.44 M EUR. In the previous year, Current Liabilities was 126.21 M EUR — a change of -60.83% (lower).

Current Liabilities

49.44 MEUR

YoY

-60.83%

Last updated:

Current Liabilities of Stratec Se is 2026 49.44 M EUR. Current Liabilities of Stratec Se was 2025 126.21 M EUR. It decreases by -60.83% lower compared to the previous year.
Access this data via the Eulerpool API

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stratec Se stock

Current Liabilities of Stratec Se is 49.44 M EUR in 2026.

Current Liabilities of Stratec Se changed from 126.21 M EUR to 49.44 M EUR, representing a -60.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Stratec Se since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Stratec Se historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Stratec Se

All Key Metrics — Stratec Se